Search

everythinglearnresearchcommunity

for

Search:↓

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The research provides a gene-based framework for hair biology, highlighting the Hippo pathway's importance and suggesting links between hair disorders, cancer pathways, and the immune system.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Vav2 changes how hair follicle stem cells' genes work as they age, which might improve regeneration but also raise cancer risk.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Targeted cancer therapies often cause serious skin problems that need careful management.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Dutasteride works better than finasteride for preventing and treating prostate cancer.